Search for Johnson & Johnson Co Inc and
  1. April 9, 2014

    Price of hepatitis C drug attacked

    Gilead Sciences is facing mounting pressure over its new $1,000-a-day hepatitis C drug after the World Health Organisation...

  2. April 1, 2014

    Drugmakers learn to blend commerce with philanthropy in Africa

    Africa has rarely been a source of good publicity for big pharma. But two events this week suggest the drugs industry is...

Special Reports

  1. Doing Business in Liberia 2012

    The country is suffering from a seven-year itch...
  2. Doing Business in Wallonia

    Wallonia, the French-speaking region of Belgium, is rethinking an economy traditionall...
Search more Special Reports on this topic.

  1. March 14, 2014

    Alejandro Zaffaroni, life scientist and entrepreneur, 1923-2014

    As the second world war drew to a close in 1945, Alejandro Zaffaroni hitched a ride on a US military cargo ship from his...

  2. March 11, 2014

    Big pharma lobbies for more poppies as painkiller demand surges

    Big pharma has warned Australia to expand its poppy growing industry beyond the remote island of Tasmania amid fears the...

  3. March 10, 2014

    Reckitt Benckiser to buy K-Y lubricants

    Reckitt Benckiser, the UK producer of Durex condoms, is to buy the K-Y brand of sexual lubricants as it increases its focus...

  4. January 21, 2014

    J&J sees ‘exceptional’ growth amid drug successes

    Johnson & Johnson trumpeted “exceptional” growth in its pharmaceuticals business on Tuesday as the US healthcare group reaps...

  5. January 16, 2014

    Carlyle joins M&A flurry with J&J unit purchase

    Carlyle, the private equity firm, has bought a unit of healthcare company Johnson & Johnson in a $4.15bn deal, joining the...

  6. December 26, 2013

    Ethics: End of the hard sell?

    When Johnson & Johnson wanted to boost prescriptions of Natrecor, a heart medicine, it channelled more than $100,000 through...

  7. December 24, 2013

    Carlyle in exclusive talks to buy J&J blood testing unit

    Carlyle has entered exclusive talks with Johnson & Johnson to buy its blood testing unit in what would be about a $4bn deal,...

  8. December 12, 2013

    Avon: Hard to cover up

    A job promotion seems like a good idea at the time. Yet it is natural to wonder if Sheri McCoy regrets taking over the chief...

  9. December 11, 2013

    J&J and Novartis mull appeal against €16m EU fines

    Johnson & Johnson and Novartis are considering whether to appeal against EU antitrust fines of €16m imposed this week for...

  10. December 2, 2013

    Big companies in end-of-year bond rush

    Large corporate borrowers seeking to raise the last batch of funding for 2013 could sell close to $30bn in investment-grade...

  11. November 20, 2013

    J&J to pay $2.5bn to settle suits over faulty artificial hips

    Johnson & Johnson has agreed to pay $2.5bn to settle claims from 8,000 US patients who used artificial hips made by its...

  12. MBA blog

    November 18, 2013

    Transforming ideas into impact

    After nine months of planning and recruiting, this past weekend my colleagues at MIT Chief and I finally hosted the 3rd...

  13. FT Alphaville

    November 5, 2013

    The (early) Lunch Wrap

    Good morning New York, FT ALPHAVILLE Spot the industry plagued by wrongdoing and huge fines: The fine that really made Dan...

  14. FT Alphaville

    November 5, 2013

    Spot the industry plagued by wrongdoing and huge fines

    No, not everybody’s favourite inside trading hedge fund. The fine that really made us gasp this week was the $2.2bn penalty...

  15. November 4, 2013

    J&J’s enterprising sales staff

    Selling Johnson & Johnson’s antipsychotic medicine to children was neither easy nor legal a decade ago, but enterprising...

  16. November 4, 2013

    J&J hit by fines of more than $2.2bn

    Johnson & Johnson is to pay more than $2.2bn in fines to US federal and state authorities for kickbacks and promotion of its...

  17. November 3, 2013

    Women at business school – Jessica Smith, associate director of MBA admissions

    Jessica Smith is associate director of MBA Admissions and head of career services for Iese Business School in North America....

  18. October 2, 2013

    Johnson & Johnson: never say never

    Johnson & Johnson will never break up. Its focus on continuity is acute. The current boss has been at the company for 25...

  19. September 29, 2013

    Pregnancy apps raise fresh privacy concerns

    The computer engineers at BabyCenter are often among the first people women tell they are pregnant. Mothers-to-be go to...

  20. September 23, 2013

    Bribery claims infect drug companies’ dealings in China

    It began as a rumour on a Chinese social media site in July, but the impact has swiftly spread around the world: allegations...

  21. September 16, 2013

    South Korea probes Celltrion over insider trading

    South Korean regulators are investigating whether the chief executive of the country’s leading biopharmaceutical company...

  22. September 10, 2013

    GlaxoSmithKline under pressure over threat of US Advair generic

    GlaxoSmithKline’s shares came under pressure on Tuesday after US regulators issued draft guidelines raising the prospect of...

  23. Business Blog

    September 3, 2013

    Introducing Steve & Stephen, the new couple trying to save Nokia (again)

    First came Ben & Jerry’s. Now we have a new brand: Steve & Stephen. It sounds like a men’s hairdressing salon, but turns out...

  24. July 30, 2013

    Advertising and the Mobile Mind Shift

    Advertising spending is on the rise. But advertising effectiveness continues to decline. The reason is simple. As the number...

  25. July 9, 2013

    Supercomputers: Battle of the speed machines

    With its flying buttresses and domed roof, the Terascale Simulation Facility at the Lawrence Livermore National Laboratory...

  26. July 1, 2013

    Drugmakers: binding agents

    Big pharma and generic drugmakers are often at loggerheads. But they may need each other more than they care to admit. Aspen...

  27. June 28, 2013

    ‘Biosimilar’ drug ruling to hit Big Pharma

    European regulators have approved the first generic versions of a complex biological medicine, paving the way for...

  28. June 24, 2013

    Tenet deal unable to buoy US indices

    Deal news provided one of the lone bright spots for US stocks as Vanguard Health Systems and Tenet Healthcare rose while...

  29. June 9, 2013

    Try before you buy

    As competition for top MBA talent increases, more companies are seeking to convert their student summer interns into...

  30. June 6, 2013

    Pfizer chief looks to joint ventures to bolster drug development

    Pfizer, the US drugs group, sees scope for joint ventures with competitors for developing a range of drugs and expanding in...

  31. June 2, 2013

    Advertising groups resist late payment moves by clients

    Advertising agency groups are pushing back against attempts by consumer products companies such as Mondelez International...

  32. FT Alphaville

    May 31, 2013

    The 6am Cut London

    Japanese stocks rebounded after yesterday’s slide, following reports that Japan’s pension fund may boost stock holdings and...

  33. May 30, 2013

    Consumer giants turn screw on ad agencies

    Some of the world’s largest consumer products groups are delaying payments to advertising agencies and commodity producers...

  34. May 29, 2013

    Smithfield rises as S&P 500 heads lower

    US stocks stumbled on Wednesday as nine of the ten S&P 500 sectors finished lower, with Smithfield Foods standing out after...

  35. May 19, 2013

    Pimco shuns ‘grim’ high yield sectors

    Investors should avoid US shares offering high levels of dividend income because valuations have reached risky levels, says...

  36. FT Alphaville

    May 9, 2013

    It's not finance, it's Cy-fi

    Nanex, the market analysts who like to create visual representations of the markets, have animated half a second of trading...

  37. May 3, 2013

    Growth outside QE required to curb distortions in asset prices

    We are all bond investors at the moment, and that is not ideal. As the calendar flipped into May this week, the S&P 500...

  38. April 30, 2013

    US woes take gloss off Avon sales

    Avon said it continued to face problems in its US and China businesses, even as the cosmetics seller’s turnround efforts...

Search for Johnson & Johnson Co Inc and